𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biodistribution of ultrasmall iron oxide particles in the rat liver

✍ Scribed by Bernard E. Van Beers; Christine Sempoux; Roland Materne; Monique Delos; Anne M. Smith


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
335 KB
Volume
13
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Ferumoxtran, an ultrasmall superparamagnetic iron oxide particle, can be located in several tissue compartments in the liver, namely the extracellular space (blood and interstitium), reticuloendothelial cells, and possibly hepatocytes. To better understand the compartmental distribution of ferumoxtran in the liver, we performed a longitudinal study in the rat using microscopy and magnetic resonance imaging. At light microscopy, no substantial cellular uptake of ferumoxtran was observed before one hour after injection. With a dose of 15 ΞΌmol Fe/kg, the number of ferumoxtran particles in the reticuloendothelial cells peaked between one and four hours and with a 150 ΞΌmol Fe/kg dose, it peaked between eight and 24 hours. Within hepatocytes, only sparse particles were observed with electron microscopy, at a dose of 150 ΞΌmol Fe/kg. Imaging performed up until one hour after ferumoxtran injection showed a significant increase in liver signal intensity on T1‐weighted images. These results suggest that ferumoxtran mainly acts as an extracellular agent for at least one hour in the rat and that reticuloendothelial accumulation peaks at later time points. Substantial uptake within hepatocytes did not occur. J. Magn. Reson. Imaging 2001;13:594–599. Β© 2001 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Theory of nonexponential NMR signal deca
✍ J.H. Jensen; R. Chandra πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 125 KB

A quantitative theory is proposed for the nonexponential NMR proton signal decay observed in liver with iron overload or superparamagnetic iron oxide particles. This effect occurs for Carr-Purcell-Meiboom-Gill (CPMG) sequences and is argued to be a direct consequence of the strong magnetic field inh

Applications of ultrasmall superparamagn
✍ Ed X. Wu; Haiying Tang; Jens H. Jensen πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 324 KB

## Abstract Ultrasmall superparamagnetic iron oxide nanoparticles have been widely used during the past decade as MR intravascular contrast agents in the study of animal models. Such agents enhance both __T__~1~ and __T__~2~/__T__~2~\* relaxation, although for animal studies it is the later type of

Diagnostic efficacy and safety of MRI of
✍ Dimitris T. Kehagias; Athanassios D. Gouliamos; Vassilios Smyrniotis; Lambros J. πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 353 KB

## Abstract The purpose of this study was to evaluate the diagnostic efficacy and safety of an intravenous injection of magnetic resonance imaging (MRI) contrast agent, SH U 555 A, in adult patients with known focal liver lesions. Pre‐ and post‐contrast image sets were obtained in 19 patients after

RES-specific imaging of the liver and sp
✍ Christoph Bremer; Thomas Allkemper; Joerg Baermig; Peter Reimer πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 361 KB

The purpose of this study was to determine the dependency of liver-and spleen-enhancement on particle size and dose of bolus-injectable iron oxides designed for bloodpool MR-angiography (MRA). The superparamagnetic iron oxide SHU 555 A [particle size 65 nm (group 1)] and three derivatives designed f